Addressing unmet needs in the treatment of COPD

por Patalano, Francesco, Banerji, Donald, D’Andrea, Peter, Fogel, Robert, Altman, Pablo, Colthorpe, Paul
Publicado 2014

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study

por LaForce, Craig, Feldman, Gregory, Spangenthal, Selwyn, Eckert, Joerg H, Henley, Michelle, Patalano, Francesco, D’Andrea, Peter
Publicado 2016

Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study

por Wang, Chen, Sun, Tieying, Huang, Yijiang, Humphries, Michael, Bai, Lingyan, Li, Lilly, Wang, Qian, Kho, Pearl, Firth, Roz, D’Andrea, Peter
Publicado 2015

A Review of the Unique Drug Development Strategy of Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate: A First-in-Class, Once-Daily, Single-Inhaler, Fixed-Dose Combinat...

por Brittain, Dominic, D’Andrea, Peter, Gruen, Emilie, Hosoe, Motoi, Jain, Devendra, Jauernig, Juergen, Pethe, Abhijit, Scosyrev, Emil, Tanase, Ana-Maria, Tillmann, Hanns-Christian
Publicado 2022

Triple Therapy with Mometasone/Indacaterol/Glycopyrronium or Doubling the ICS/LABA Dose in GINA Step 4: IRIDIUM Analyses

por van Zyl-Smit, Richard N., Kerstjens, Huib A. M., Maspero, Jorge, Tanase, Ana-Maria, Lawrence, David, Mezzi, Karen, D’Andrea, Peter, Chapman, Kenneth R.
Publicado 2023

Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data

por D’Urzo, Anthony D, Kerwin, Edward M, Chapman, Kenneth R, Decramer, Marc, DiGiovanni, Robert, D’Andrea, Peter, Hu, Huilin, Goyal, Pankaj, Altman, Pablo
Publicado 2015

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study

por Chapman, Kenneth R, Beeh, Kai-Michael, Beier, Jutta, Bateman, Eric D, D’Urzo, Anthony, Nutbrown, Robert, Henley, Michelle, Chen, Hungta, Overend, Tim, D’Andrea, Peter
Publicado 2014

Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study

por Sekerel, Bulent Enis, Nell, Haylene, Laki, Istvan, Pak, Tatiana, Contreras, Edgar, Kolarz, Adam, D’Andrea, Peter, Manga, Volkan, Jain, Monish, Vaidya, Soniya, Valentin, Michele, Sen, Biswajit
Publicado 2023

One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PAL...

por Chapman, Kenneth, van Zyl-Smit, Richard, Maspero, Jorge, Kerstjens, Huib A M, Gon, Yasuhiro, Hosoe, Motoi, Tanase, Ana-Maria, Pethe, Abhijit, Shu, Xu, D’Andrea, Peter
Publicado 2021

Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Pati...

por van Zyl-Smit, Richard N, Chapman, Kenneth R, Kerstjens, Huib A M, Gessner, Christian, Sagara, Hironori, Tanase, Ana-Maria, Hosoe, Motoi, Pethe, Abhijit, Lawrence, David, Tillmann, Hanns-Christian, D’Andrea, Peter
Publicado 2023